Arcturus Therapeutics Ownership | Who Owns Arcturus Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Arcturus Therapeutics Ownership Summary

Arcturus Therapeutics is owned by 98.39% institutional investors, 8.46% insiders. Federated hermes is the largest institutional shareholder, holding 17.35% of ARCT shares. Federated Hermes Kaufmann Growth is the top mutual fund, with 8.99% of its assets in Arcturus Therapeutics shares.

ARCT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Arcturus Therapeutics	98.39%	8.46%	-6.85%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Federated hermes	4.69M	17.35%	$79.66M
Blackrock funding, inc. /de	2.99M	11.05%	$50.73M
Nikko asset management americas	2.07M	7.63%	$34.94M
Sumitomo mitsui trust	2.07M	7.63%	$35.04B
Ark investment management	1.93M	7.15%	$32.82M
Vanguard group	1.68M	6.22%	$28.59M
State street	1.33M	4.90%	$22.50M
Schonfeld strategic advisors	849.08K	3.14%	$14.41M
Woodline partners lp	806.91K	2.98%	$13.69M
Dimensional fund advisors lp	707.40K	2.61%	$12.00M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bioimpact capital	459.94K	1.11%	$7.81M
Ikarian capital	200.00K	0.46%	$3.39M
Nikko asset management americas	2.07M	0.38%	$34.94M
Empire life investments	279.46K	0.30%	$4.74M
Ark investment management	1.93M	0.27%	$32.82M
Federated hermes	4.69M	0.17%	$79.66M
Pdt partners	90.30K	0.14%	$1.53M
J. goldman & co lp	296.05K	0.13%	$5.02M
Belmont capital	40.00K	0.11%	$678.80K
Woodline partners lp	806.91K	0.09%	$13.69M

Top Buyers

Holder	Shares	% Assets	Change
Balyasny asset management	548.76K	0.01%	548.76K
Schonfeld strategic advisors	849.08K	0.08%	479.48K
J. goldman & co lp	296.05K	0.13%	296.05K
Bioimpact capital	459.94K	1.11%	240.44K
Ikarian capital	200.00K	0.46%	200.00K

Top Sellers

Holder	Shares	% Assets	Change
Nikko asset management americas	2.07M	0.38%	-250.24K
Millennium management	-	-	-236.07K
Sumitomo mitsui trust	2.07M	0.02%	-210.66K
Ark investment management	1.93M	0.27%	-167.19K
Royce & associates lp	-	-	-155.80K

New Positions

Holder	Shares	% Assets	Change	Value
J. goldman & co lp	296.05K	0.13%	296.05K	$5.02M
Ikarian capital	200.00K	0.46%	200.00K	$3.39M
Boothbay fund management	58.94K	0.02%	58.94K	$1.00M
Caption management	9.80K	0.00%	9.80K	$166.31K
Mai capital management	381.00	-	381.00	$6.47K

Sold Out

Holder	Change
Capital performance advisors llp	-2.00
Gps wealth strategies group	-10.00
Farther finance advisors	-47.00
Northwestern mutual wealth management	-58.00
Dunhill financial	-60.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	155	-9.36%	26,627,173	1.41%	98	1.05%	69	-14.81%	47	-6.00%
Sep 30, 2024	170	-4.49%	26,254,877	-0.08%	97	1.02%	81	5.19%	49	-27.94%
Jun 30, 2024	178	-5.82%	26,276,502	-3.48%	97	0.95%	77	-15.38%	68	11.48%
Mar 31, 2024	189	9.25%	27,224,704	7.13%	101	1.11%	91	-	61	15.09%
Dec 31, 2023	173	11.61%	25,412,469	1.02%	95	1.06%	91	26.39%	53	-1.85%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Federated Hermes Kaufmann Growth	2.44M	8.99%	-
Federated Hermes Kaufmann R	2.44M	8.99%	-
Federated Hermes Kaufmann Small Cap A	2.20M	8.11%	-
Federated Hermes Kaufmann Small Cap Grow	2.20M	8.11%	-
ARK Genomic Revolution ETF	1.93M	7.13%	74.58K
ARK Genomic Revolution	1.91M	7.05%	-177.95K
Nikko AM ARK Pstv Chg Innovt P JPY Acc	1.70M	6.27%	-70.40K
Vanguard Total Stock Mkt Idx Inv	724.72K	2.68%	-
Vanguard US Total Market Shares ETF	723.64K	2.67%	-
iShares Russell 2000 ETF	623.42K	2.30%	-5.39K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 15, 2024	Chivukula Pad	Chief Scientific Officer & COO	Sell	$249.12K
Jun 12, 2024	SASSINE ANDY	Chief Financial Officer	Sell	$1.60M
Jun 05, 2024	Chivukula Pad	Chief Scientific Officer & COO	Sell	$5.13K
Jun 03, 2024	Chivukula Pad	Chief Scientific Officer & COO	Sell	$1.04M
Mar 25, 2024	Chivukula Pad	Chief Scientific Officer & COO	Sell	$610.57K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	1
2024 Q2	-	3
2024 Q1	-	2
2023 Q4	-	2
2023 Q3	-	5

ARCT Ownership FAQ

Who Owns Arcturus Therapeutics?

Arcturus Therapeutics shareholders are primarily institutional investors at 98.39%, followed by 8.46% insiders and -6.85% retail investors. The average institutional ownership in Arcturus Therapeutics's industry, Biotech Stocks , is 68.48%, which Arcturus Therapeutics exceeds.

Who owns the most shares of Arcturus Therapeutics?

Arcturus Therapeutics’s largest shareholders are Federated hermes (4.69M shares, 17.35%), Blackrock funding, inc. /de (2.99M shares, 11.05%), and Nikko asset management americas (2.07M shares, 7.63%). Together, they hold 36.02% of Arcturus Therapeutics’s total shares outstanding.

Does Blackrock own Arcturus Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Arcturus Therapeutics.

Who is Arcturus Therapeutics’s biggest shareholder by percentage of total assets invested?

Bioimpact capital is Arcturus Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.11% of its assets in 459.94K Arcturus Therapeutics shares, valued at 7.81M$.

Who is the top mutual fund holder of Arcturus Therapeutics shares?

Federated Hermes Kaufmann Growth is the top mutual fund holder of Arcturus Therapeutics shares, with 8.99% of its total shares outstanding invested in 2.44M Arcturus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools